|
Highlight
Reprograms cancer-associated fibroblasts to dismantle tumor barriers and improve immune-cell access to solid tumors.
Innovation
Cancer-associated fibroblasts (CAFs) create a physical and immunosuppressive barrier that limits the effectiveness of CAR-T and other immunotherapies in solid tumors. This technology uses transcription factor-based...
|